Pain, Postoperative Clinical Trial
Official title:
Quantifying Pain and Narcotic Usage Following Orthopedic Surgery Using a Text-Messaging Robot
This study aims to 1) observe the course of pain, 2) utilization of opioid pain medication, and 3) possible effect of a behavioral intervention delivered via an automated mobile phone messaging robot in patients undergoing surgical treatment of a traumatic orthopaedic injury.
Adult patients presenting to a University Hospital Level 1 trauma center indicated for
operative fixation of a traumatic upper or lower fracture were considered for the study. A
partial Health Insurance Portability and Accountability Act waiver was granted for this
investigation to allow research team members to review potential subject's medical record for
any condition meeting exclusion criteria. Eligible patients consenting to the study will be
assigned a unique study identification number (ID). A master database linking patient ID to
patient name and medical record number will be housed on a password protected and encrypted
departmental server location, which only research personnel can access.
Participants will complete a basic demographics survey and preoperative/baseline patient
reported outcome surveys at enrollment, including the Patient-reported outcomes measurement
information system (PROMIS) Pain Intensity 1A short form, PROMIS Pain Intensity 3A short
form, PROMIS Pain Interference 8A short form, and PROMIS 8A Emotional Distress-Anxiety 8A
short forms. Following completion of these surveys, subjects will be randomized in a 1:1
ratio using a random number generator into one of two study groups. The intervention group
will receive mobile messages communicating the behavior intervention following surgery. The
control group will not receive the intervention. Subjects will not be blinded to their study
group. Participants randomized to the intervention group were subsequently enrolled into the
automated mobile messaging protocol and received a confirmation message welcoming them to the
study, which was reviewed with them by the research assistant. Subjects were instructed that
they were only required to read all messages, no responses were required. No other aspects of
patient care including surgical approaches, medications prescribed, or postoperative
instructions differ between groups.
After completion of enrollment and assignment of study group, each participant's medical
record will be reviewed to obtain the following data that will be recorded in the research
study database: Age, Sex, BMI, Medical Comorbidities, Psychological Comorbidities, Substance
Abuse History, and presence of preoperative outpatient opioid pain medication utilization.
Subjects in the intervention group will being receiving the mobile messaging intervention the
day following surgery. The mobile messaging intervention consists of twice per day mobile
messages, morning and evening, starting on postoperative day one and ending on postoperative
day 14. Messages communicated to study participants employ the principles of Acceptance and
Commitment therapy, otherwise known as ACT, which has been used in the treatment of chronic
pain. Prior to discharge, patients will be seen by a research team member to review the
opioid pain medication they are prescribed at discharge and instructed to have their pill
bottle available to them to provide a pill count at follow-up.
A single instance of follow-up will take place on postoperative day 14. This will occur
either in clinic or over the phone with a research team member. At this time, participants
will be asked how many tablets of their opioid pain medication they consumed since discharge
and to confirm with the amount tablets remaining. Additionally, subjects will fill out a
second set of the patient reported outcome surveys completed at enrollment. Collection of
these follow-up items marks the end of the subject's participation in the study. No data
collection planned following the two week study period.
The study hypothesis is that subjects receiving the behavior intervention delivered via an
automated mobile messaging robot would report consuming less opioid pain medication during
the study period, and demonstrate better patient reported outcome survey scores than controls
at follow-up.
An initial pilot cohort was recruited in order to obtain the data to run the power analysis
that determined the population size for the randomized portion of the study. The preliminary
study recorded the amount of opioid medication tablets utilized by these patients over a
two-week postoperative period.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05480111 -
The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy
|
Phase 4 | |
Completed |
NCT06129305 -
Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
|
||
Completed |
NCT04401826 -
Micro-surgical Treatment of Gummy Smile
|
N/A | |
Recruiting |
NCT04020133 -
the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction.
|
N/A | |
Completed |
NCT03023462 -
Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair
|
N/A | |
Completed |
NCT03652103 -
Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy
|
Phase 4 | |
Completed |
NCT03546738 -
Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery
|
N/A | |
Terminated |
NCT03261193 -
ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain
|
Phase 3 | |
Withdrawn |
NCT03528343 -
Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy
|
Phase 1/Phase 2 | |
Completed |
NCT02525133 -
Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty
|
Phase 3 | |
Completed |
NCT03244540 -
Regional Analgesia After Cesarean Section
|
Phase 4 | |
Enrolling by invitation |
NCT05316168 -
Post Operative Pain Management for ACL Reconstruction
|
Phase 3 | |
Recruiting |
NCT04130464 -
Intraperitoneal Infusion of Analgesic for Postoperative Pain Management
|
Phase 4 | |
Enrolling by invitation |
NCT04574791 -
Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty
|
N/A | |
Completed |
NCT04073069 -
Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults
|
Phase 4 | |
Completed |
NCT04526236 -
Influence of Aging on Perioperative Methadone Dosing
|
Phase 4 | |
Recruiting |
NCT05351229 -
Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery
|
Phase 4 | |
Enrolling by invitation |
NCT05543109 -
Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block
|
N/A | |
Completed |
NCT05346588 -
THRIVE Feasibility Trial
|
Phase 3 | |
Completed |
NCT04919317 -
Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty
|
Phase 2 |